Company: AMTX
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001437749-25-015301
Chunk: 1

Company: AEMETIS, INC
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
   54,693   56,201 
 Series A preferred units ($126,759 and $126,593 respectively from VIE)   126,759   126,593 
 Other long term liabilities ($474 and $475 respectively from VIE)   5,109   5,142 
 Total long term liabilities   348,612   379,262 
         
 Stockholders' deficit:         
 Common stock, $0.001 par value; 80,000 authorized; 54,042 and 51,139 shares issued and outstanding each period, respectively   54   51 
 Additional paid-in capital   313,075   305,329 
 Accumulated deficit   (587,471)  (562,942)
 Accumulated other comprehensive loss   (6,353)  (6,366)
 Total stockholders' deficit   (280,695)  (263,928)
 Total liabilities and stockholders' deficit  $242,518  $259,302 

The accompanying notes are an integral part of the financial statements.

       4

      Table of Contents

AEMETIS, INC.

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(Unaudited, in thousands except for loss per share)

       For the three months ended March 31, 

       2025 

       2024 

       Revenues 
       
      $
      42,886

      $
      72,634

       Cost of goods sold 

      47,966

      73,246

       Gross loss 

      (5,080
      )

      (612
      )

       Selling, general and administrative expenses 

      10,475

      8,850

       Operating loss 

      (15,555
      )

      (9,462
      )

       Other expense (income): 

       Interest expense 

       Interest rate expense 

      11,018

      9,092

       Debt related fees and amortization expense 

      2,675

      1,421

       Accretion and other expenses of Series A preferred units 

      2,279

      3,311

       Other (income) expense 

      (215
      )

      67

       Loss before income taxes 

      (31,312
      )

      (23,